[1] 刘伟,吕国士. 放射性肝损伤的影像学研究概况. 实用放射学杂志,2010,26(8):1205-1207. [2] Benson R,Madan R,Kilambi R,et al.Radiation induced liver disease:A clinical update. J Egyp N Ca Inst,2016,28:7-11. [3] Huang Y,Chen SW,Fan CC,et al.Clinical parameters for predicting radiation-induced liver disease after intrahepatic reirradiation for hepatocellular carcinoma. Radiat Oncol,2016,11:89. [4] Jung J,Yoon SM,Kim SY,et al.Radiation-induced liver disease after stereotactic body radiotherapy for small hepatocellular carcinoma:clinical and dose-volumetric parameters. Radiat Oncol,2013,8:249. [5] Liang SX,Huang XB,Zhu XD,et al.Dosimetric predictor identification for radiation induced liver disease after hypofractionated conformal radiotherapy for primary liver carcinoma patients with Child-Pugh grade A cirrhosis. Radiat Oncol,2011,98:265-269. [6] Lai YL,Kuo YC,Lai HC,et al.Early radiation-induced liver toxicities are associated with poor survival in patients with advanced hepatocellular carcinoma. Asia Pac J Clin Oncol,2016,12:437-443. [7] Kim TH,Kim DY,Park JW,et al.Dose-volumetric parameter spredicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three dimensionalconformal radiotherapy. Int J Radiat Oncol Biol Phys,2007,67(1):225-231. [8] Gencel O,Naziroglu M,Celik O,et al.Selenium and vitamin emodulates radiation induced liver toxicity in pregnant and nonpregnant rat:effects of colemanite and hematite shielding. Biol Trace Elem Res,2010,135:253-263. [9] Kim HG,Jang SS,Lee JS,et al.Meyer prevents radiation-induced liver injury via modulation of oxidative stress and apoptosis. J Ginseng Res,2017,41(2):159-168. [10] Wu ZF,Zhang JY,Shen XY,et al.A mouse radiation-induced liver disease model for stereotactic body radiation therapy validated in patients with hepatocellular carcinoma. Med Phys,2016,43(17):4349. [11] Stenmark MH,Cao Y,Wang H,et al.Estimating functional liver reserve following hepatic irradiation:adaptive normal tissue response models. Radiother Oncol,2014,111:418-423. [12] Guha C,Kavanagh BD.Hepatic radiation toxicity:avoidance and amelioration. Semin Radiat Oncol,2011,21:256-263. [13] Marks LB,Yorke ED,Jackson A,et al.Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys,2010,76:10-19. [14] Feng J,Chen SB,Wu SJ,et al.Quantitative analysis of contrast-enhanced ultrasonography in acute radiation-induced liver injury:An animal model. Exp Ther Med,2015,10:1807-1811. [15] Fukugawa Y,Namimoto T,Toya R,et al.Radiation-induced liver injury after 3D-conformal radiotherapy for hepatocellular carcinoma:Quantitative assessment using Gd-EOB-DTPA-enhanced MRI. Acta Med Okayama,2017,71(1):25-29. [16] Kobashi K,Prayongrat A,Kimoto T,et al.Assessing the uncertainty in a normal tissue complication probability difference (NTCP):radiation-induced liver disease(RILD) in liver tumour patients treated with proton vs X-ray therapy. J Radiat Res,2018,59(suppl 1):i50-i57. [17] Gong HY,Hu WG,Hu QY,et al.Radiation-induced pulmonary injury accelerated pulmonary metastasis in a mouse model of breast cancer. Oncol Lett,2015,10:3613-3618. [18] Chapman TR,Bowen SR,Schaub SK,et al.Toward consensus reporting of radiation-induced liver toxicity in the treatment of primary liver malignancies:Defining clinically relevant endpoints. Pract Radiat Oncol,2018,8(3):157-166. [19] Ichikawa S,Motosugi U,Oguri M,et al.Magnetic resonance elastography for prediction of radiation-induced liver disease after stereotactic body radiation therapy. Hepatology,2017,66(2):664-665. [20] 吕东来,陆林,卢虎生,等. 三维适形放射治疗原发性肝癌患者发生放射性肝损伤相关因素分析.实用肝脏病杂志,2017,20(1):89-92. |